177Lu-NYM032 Injection

Lutetium-177-NYM032 · Norroy Bioscience Co., LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-NYM032 Injection, covering 2025-05-21 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC [Phase 1, Phase 2]